NLS Pharmaceutics News

6-K: Report of foreign private issuer (related to financial reporting)

Dec 4 16:17 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 15 17:03 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 12 16:06 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 5 08:01 ET

6-K: Report of foreign private issuer (related to financial reporting)

Oct 22 16:04 ET

6-K: Report of foreign private issuer (related to financial reporting)

Oct 18 16:35 ET

6-K: Report of foreign private issuer (related to financial reporting)

Oct 11 07:03 ET

6-K: Report of foreign private issuer (related to financial reporting)

Sep 25 08:15 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 26 16:42 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 15 16:09 ET

6-K: Report of foreign private issuer (related to financial reporting)

Jul 1 08:13 ET

6-K: Report of foreign private issuer (related to financial reporting)

Jun 25 16:36 ET

6-K: Report of foreign private issuer (related to financial reporting)

Jun 6 17:02 ET

20-F: FY2023 Annual Report

May 15 22:33 ET

NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 15 16:05 ET

NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 21 17:18 ET

NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 09:03 ET

NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 6, 2023 16:44 ET

NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 9, 2023 08:30 ET

NLS Pharmaceutics | 20-F: FY2022 Annual Report

May 5, 2023 16:36 ET